Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) COVID-19 vaccines (15)
- Prescription medicines (19)
- Advertising (17)
- Regulatory compliance (17)
- Therapeutic goods regulation (17)
- COVID-19 (15)
- Non-prescription medicines (11)
- Listed medicines (10)
- Complementary medicines (9)
- Manufacturing (9)
- Legislation (8)
- Over the counter (OTC) medicines (7)
- Compliance and enforcement hub (5)
- Medicine safety (5)
- Vaping hub (5)
- Australian Register of Therapeutic Goods (ARTG) (4)
- Medicinal cannabis hub (4)
- Scheduling (national classification system) (4)
- Import and export (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Shortages (3)
- Alert/Advisory (2)
- Assessed listed medicines (2)
- Labelling and packaging (2)
- Medical devices safety (2)
- Safety (2)
- Cosmetics (1)
- Sunscreens (1)
- Weight loss products (1)
Search
15 result(s) found, displaying 1 to 15
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has approved Moderna Australia’s application to transition its COVID-19 vaccine, SPIKEVAX (elasomeran), from provisional to full registration.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThis is the first vaccine provisionally approved by the TGA that is designed to specifically target the Omicron variants BA.4/BA.5 and follows provisional approval of the Pfizer BA.1 Omicron/original bivalent vaccine.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.